Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
Objective. To evaluate the efficacy and safety of rituximab in multiple sclerosis in a clinical practice setting. Methods. Clinical data for all adult patients with multiple sclerosis (MS) treated with off-label rituximab at a single MS center in Lebanon between March 2008 and April 2017 were retros...
Saved in:
| Main Authors: | Bassem I. Yamout, Nabil K. El-Ayoubi, Johny Nicolas, Yehya El Kouzi, Samia J. Khoury, Maya M. Zeineddine |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2018/9084759 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and tolerability of rituximab in the treatment of systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2023-04-01) -
Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis
by: George Vartzelis, et al.
Published: (2019-01-01) -
Rituximab-Induced Hypersensitivity Pneumonitis in Multiple Sclerosis: A Rare Phenomenon
by: SS Jayanth, et al.
Published: (2025-01-01) -
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
by: Tamara Castillo-Trivino, et al.
Published: (2013-01-01) -
Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
by: Trygve Holmøy, et al.
Published: (2018-01-01)